- UAE medical device market is AED 8B+ (2025) — 35% of the entire GCC total, growing 15%/year.
- UAE imports 95%+ of all medical devices; local manufacturing contributes AED 500M+ and expanding.
- MOHAP product registration fees: Class I AED 5,000–10,000; Class IIb AED 15,000–30,000; Class III AED 20,000–50,000 per product.
- First-year cost for a medical device distributor: AED 442,000–1,015,000+ (license, registrations, warehouse, staff).
- UAE is a major GCC re-export hub — AED 3B+ in medical device re-exports annually to Saudi Arabia, Qatar, and Kuwait.
- Medical devices are generally VAT-exempt (0%) in the UAE; diagnostic testing devices may attract VAT.
Updated August 2026. The UAE is the Gulf’s premier medical device market and re-export corridor. Whether you are importing surgical equipment from Germany, distributing Class III implants, or setting up a local manufacturing facility, federal registration with MOHAP (Ministry of Health and Prevention) is mandatory before any device can be sold or used in the UAE. This guide covers every step of the process: classification, MOHAP Medical Device Registration (MDR), distributor licensing, setup costs, and what Class III registration actually requires.
UAE Medical Device Market at a Glance
The UAE medical device sector is the largest in the GCC by value. Driven by world-class hospital infrastructure in Dubai and Abu Dhabi, a rapidly growing population, and the UAE’s role as a logistics hub for the wider Gulf, demand is rising across all device categories — from diagnostics and imaging to implants and surgical instruments.
| Market Metric | 2025 Data |
|---|---|
| Total UAE medical device market | AED 8B+ (approx. USD 2.2B) |
| Share of GCC medical device market | ~35% |
| Annual growth rate | ~15% per year |
| Import dependency | 95%+ of devices imported |
| Local manufacturing value | AED 500M+ and growing |
| GCC re-export value | AED 3B+ (to Saudi Arabia, Qatar, Kuwait) |
| Key private end-buyers | Mediclinic, Cleveland Clinic Abu Dhabi, NMC, private clinics, pharmacies |
| Key public end-buyers | DHA hospitals (Dubai), SEHA/DOH hospitals (Abu Dhabi), MOH clinics |
The UAE’s position as the GCC re-export hub means that obtaining MOHAP registration also unlocks access to Saudi Arabia, Qatar, and Kuwait buyers who source through Dubai’s Jebel Ali Free Zone logistics infrastructure.
UAE Medical Device Regulatory Framework
Medical device regulation in the UAE operates at both federal and emirate levels. MOHAP is the primary federal authority. However, devices sold in Dubai may require an additional DHA notification or registration, and devices sold to Abu Dhabi government hospitals may require a DOH listing as well.
| Regulator | Jurisdiction | Role |
|---|---|---|
| MOHAP | UAE Federal (all emirates) | Primary medical device registration (MDR); mandatory for all devices sold in UAE |
| DHA | Dubai | Dubai Health Authority; additional product/facility registration for DHA-regulated facilities |
| DOH | Abu Dhabi | Department of Health Abu Dhabi; tender/supplier registration for SEHA hospitals |
| ESMA | UAE Federal | Emirates Authority for Standardization; technical standards compliance (non-registration) |
Framework alignment: The UAE follows the GHTF (Global Harmonization Task Force) model, and MOHAP accepts CE Mark (EU MDR 2017/745), US FDA 510(k)/PMA, TGA (Australia), Health Canada, and PMDA (Japan) approvals as the primary conformity evidence. Devices with none of these approvals face significantly longer review timelines.
Note on MDMA vs MDR: The term “MDMA” (Medical Device Market Authorization) was the legacy name used before approximately 2018. The correct and current term is MDR — Medical Device Registration. You may still see MDMA referenced in older regulatory documents; both refer to the same registration regime under MOHAP.
Medical Device Classification in UAE (MOHAP)
UAE classification follows the GHTF/EU framework. Your device’s classification determines the registration fee, the depth of technical review, and the renewal cycle. Misclassification — particularly under-classification — is a common rejection cause.
| Class | Risk Level | Examples | MOHAP Registration Fee | Renewal |
|---|---|---|---|---|
| Class I | Low | Bandages, tongue depressors, reading glasses, hospital beds | AED 5,000–10,000 | 5 years |
| Class IIa | Medium | Contact lenses, MRI contrast agents, hearing aids, surgical gloves | AED 10,000–20,000 | 5 years |
| Class IIb | Medium-High | X-ray machines, infusion pumps, ventilators, surgical lasers | AED 15,000–30,000 | 5 years |
| Class III | High | Cardiac stents, implantable pacemakers, hip/knee implants, IVD diagnostics | AED 20,000–50,000 | 2 years (accelerated review cycle) |
| IVD | Variable | Blood glucose meters, PCR test kits, COVID-19 antigen tests, haematology analysers | AED 10,000–40,000 | 2–5 years; WHO PQ preferred pathway |
IVD (In-Vitro Diagnostic) devices follow a separate MOHAP pathway. For IVDs submitted with WHO Prequalification (PQ), MOHAP typically provides faster approval. PCR-based diagnostic kits, HIV tests, and other communicable disease diagnostics are prioritized.
MOHAP Medical Device Registration Process (Step-by-Step)
MOHAP medical device registration (MDR) is a structured five-step process. The timeline ranges from 3 months for straightforward Class I devices with full CE documentation, to 12+ months for novel Class III products. Below is the standard pathway as of 2026.
| Step | Action | Who Does It | Typical Timeline |
|---|---|---|---|
| Step 1 | UAE Authorized Distributor/Importer registration with MOHAP (company pre-registration) | UAE-based company | 4–12 weeks (one-time per company) |
| Step 2 | Product dossier preparation: technical file, CE/FDA/TGA certification, Arabic labeling, clinical performance data, manufacturer declaration | Manufacturer + UAE distributor | 4–16 weeks (depends on gaps) |
| Step 3 | MOHAP online portal submission (Sheryan platform); fee payment; screening for completeness | UAE distributor | 2–4 weeks for screening |
| Step 4 | MOHAP technical review: risk classification verification, clinical data assessment, labeling review, conformity evaluation | MOHAP reviewers | 3–12 months (Class I: 3–4 months; Class III: 9–12 months) |
| Step 5 | MOHAP approval issued; MDR certificate issued; annual maintenance fee payment; 5-year renewal (2-year for Class III) | MOHAP + UAE distributor | Ongoing |
Key dossier requirements: Every MOHAP submission must include a valid CE Mark (or FDA 510(k)/PMA/TGA equivalent), the manufacturer’s ISO 13485 certificate (Quality Management System for medical devices), Arabic-language labeling that meets MOHAP format requirements, a Declaration of Conformity, and clinical data or performance evaluation. Incomplete dossiers are the single most common cause of delays.
MOHAP Sheryan platform: Submissions are made via the Sheryan e-Services portal. The distributor must have a registered Sheryan account linked to their MOHAP pre-registration before any product can be submitted.
Importer and Distributor License Requirements
Before MOHAP will accept a product registration, a UAE-based authorized importer or distributor must be established. This is a hard prerequisite: foreign manufacturers cannot register devices directly with MOHAP — a UAE-resident legal entity must hold the registration and be accountable for the product in the market.
| License/Registration | Issuing Authority | Cost | Timeline |
|---|---|---|---|
| DED Commercial License (medical devices trading activity) | DED (Dubai / Abu Dhabi / emirate DED) | AED 12,000–25,000/year | 2–6 weeks |
| MOHAP Distributor Pre-Registration (mandatory for product submission) | MOHAP | AED 5,000–10,000 per company | ~3 months |
| Import permit per shipment (for registered products) | MOHAP / customs | AED 500–2,000 per permit | 3–10 working days |
| DHA Establishment Approval (if selling in Dubai Health Authority facilities) | DHA | AED 3,000–8,000 | 4–8 weeks |
| DOH Supplier Registration (for Abu Dhabi SEHA hospital tenders) | DOH / Abu Dhabi | AED 2,000–5,000 | 4–10 weeks |
VAT position: The UAE VAT law (Federal Decree-Law No. 8 of 2017) zero-rates most medical devices. Human medicine and “specified medical equipment” are zero-rated (0% VAT). However, some diagnostic consumables and non-therapeutic devices may be standard-rated at 5%. Companies must seek specific VAT classification advice from the Federal Tax Authority (FTA) for each product category.
Free zone vs mainland: Medical device companies operating from JAFZA, DAFZA, or other UAE free zones can hold a free zone license and import products through free zone facilities. However, to sell to UAE mainland hospitals and clinics, the distributor must have mainland market access — either through a mainland license, a mainland commercial agent, or the JAFZA onshore distribution permit.
Medical Device Distribution: Year 1 Cost Model
Below is a realistic first-year cost breakdown for a new UAE medical device distributor entering the market with 10 product lines at Class IIb level. Actual costs vary by device type, emirate of incorporation, and warehouse specification.
| Cost Item | Low Estimate (AED) | High Estimate (AED) | Notes |
|---|---|---|---|
| DED commercial license | 12,000 | 25,000 | Annual; emirate-dependent |
| MOHAP distributor pre-registration | 5,000 | 10,000 | One-time per company |
| MOHAP product registration × 10 products (Class IIb) | 150,000 | 300,000 | AED 15,000–30,000 per product |
| Arabic labeling + regulatory affairs per product × 10 | 100,000 | 300,000 | AED 10,000–30,000 per product |
| Warehouse (temperature-controlled) | 100,000 | 300,000 | Annual rent; cold chain adds premium |
| Medical device specialist / regulatory manager salary | 150,000 | 350,000 | Annual; senior RA staff command premium |
| DHA/DOH registrations + other emirate fees | 15,000 | 30,000 | If distributing in Dubai + Abu Dhabi |
| Total Year 1 | AED 532,000 | AED 1,315,000 | Excludes inventory, sales team, marketing |
These figures reflect regulatory and infrastructure costs only — not the cost of purchasing initial inventory, building a sales team, or market development activities such as KOL engagement with hospital procurement teams. Successful distributors typically budget an additional AED 500,000–2,000,000 for inventory and commercial setup in Year 1.
Revenue Model: UAE Medical Device Distributor
Despite the high Year 1 investment, UAE medical device distribution offers strong margin and scalability. The critical differentiation is exclusivity: exclusive distribution agreements with foreign manufacturers dramatically improve margin and defensibility.
| Revenue Scenario | Margin | Annual Revenue Potential |
|---|---|---|
| DHA/DOH government tender (high volume) | 10–20% | AED 5M–30M per tender win |
| Private hospital supply (Mediclinic, Cleveland Clinic) | 25–50% | AED 1M–10M per hospital group |
| Clinic / pharmacy channel | 30–60% | AED 500K–3M |
| GCC re-export (Saudi Arabia, Qatar, Kuwait) | 15–35% | AED 2M–20M |
| Established distributor (10 lines, 5 years) | 20–40% blended | AED 10M–50M (Year 3+); AED 50M–200M possible by Year 5 with tenders |
Government tender revenue is concentrated in large periodic contracts (often 1–3 year frameworks issued by DHA, SEHA, or MOH). Winning even one mid-size tender — for consumables used across multiple hospitals — can anchor a distributor’s revenue for years. Private hospital margins are higher but require ongoing relationship management, product training, and clinical support staffing.
Class III Medical Device Registration: Special Requirements
Class III devices represent the highest-risk category and require the most rigorous MOHAP review. If you are registering cardiac implants, neural stimulators, absorbable implants, or high-risk IVDs, the following additional requirements apply beyond the standard MDR process.
| Requirement | Standard Class I/IIa | Class III |
|---|---|---|
| Clinical evidence required | Literature review often sufficient | Full clinical investigation data or robust post-market clinical follow-up (PMCF) required |
| Notified Body involvement | Self-declaration (Class I) | Mandatory CE Certificate from EU Notified Body (or equivalent FDA PMA/TGA Class III approval) |
| Technical dossier depth | Abbreviated technical file | Full Design Dossier (DD) required; MOHAP may request additional test reports |
| Biocompatibility data | ISO 10993 summary | Full ISO 10993 biological evaluation report; cytotoxicity, sensitization, systemic toxicity |
| Registration fee | AED 5,000–20,000 | AED 20,000–50,000 |
| Review timeline | 3–6 months | 9–18 months; queries from MOHAP technical reviewers are common |
| Renewal cycle | Every 5 years | Every 2 years; post-market surveillance reports required at renewal |
| Post-market surveillance | Complaint handling system required | Active PMCF; adverse event reporting to MOHAP within 10 days of serious events; periodic safety update reports (PSUR) |
Class III registration for novel devices without existing CE Mark or FDA PMA approval is extremely difficult in the UAE and typically not attempted. MOHAP relies heavily on major market approvals as the primary conformity benchmark. Devices that are only approved in smaller markets (e.g., India CDSCO only, without CE or FDA) face near-certain rejection or multi-year delays.
Frequently Asked Questions
How does MOHAP medical device registration work in UAE?
MOHAP Medical Device Registration (MDR) is the federal approval process that authorizes a medical device for sale, import, and distribution in the UAE. A UAE-based authorized distributor or importer must first obtain MOHAP company pre-registration (the Sheryan platform account), then submit a product dossier for each device. The dossier must include: the device’s CE Mark, FDA 510(k)/PMA, or TGA approval; the manufacturer’s ISO 13485 Quality Management System certificate; a Declaration of Conformity; Arabic-language labeling meeting MOHAP format requirements; and clinical evidence appropriate to the device’s risk class. MOHAP reviews the dossier and, on approval, issues an MDR certificate. The certificate must be renewed every 5 years (or every 2 years for Class III devices). Registration is product-specific: each device model/variant requires its own MDR application and fee.
How long does medical device registration take in UAE?
Medical device registration timelines in UAE depend primarily on the device’s risk class. Class I devices with a complete, well-organized dossier and a valid CE Mark typically take 3 to 4 months from submission to MOHAP approval. Class IIa and IIb devices take 4 to 9 months on average. Class III devices — including implants, cardiac stents, and high-risk IVDs — take 9 to 18 months, as MOHAP technical reviewers conduct a detailed clinical data assessment and may raise multiple query rounds. The single largest cause of delays is an incomplete dossier: missing Arabic labeling, an expired ISO 13485 certificate, or insufficient clinical evidence routinely add 3 to 6 months. Companies that engage a UAE regulatory affairs specialist to prepare the dossier before submission typically achieve faster outcomes. Before any product submission can begin, the company must complete MOHAP distributor pre-registration, which itself takes approximately 3 months.
Does a UAE company need to be the authorized distributor for medical device registration?
Yes — this is a hard requirement under MOHAP rules. Foreign manufacturers cannot register medical devices directly with MOHAP. The registration must be held by a UAE-based legal entity (a company incorporated in a UAE emirate or free zone with appropriate mainland access) that acts as the authorized distributor or importer. This UAE entity is legally responsible for the device’s compliance, post-market surveillance, adverse event reporting, and recall actions in the UAE market. The manufacturer must provide a formal Authorization Letter to the UAE distributor, appointing them as the sole or authorized representative for the specific product in the UAE. If the distributor relationship ends, the MDR registration must be transferred to a new UAE-registered entity or it lapses. Some free zone companies can import for re-export without mainland authorization, but selling into the UAE domestic market always requires a mainland-licensed entity or a mainland commercial agent arrangement.
What are the Class III medical device registration requirements in UAE?
Class III medical device registration in UAE requires the most comprehensive submission of all device categories. At minimum, the dossier must include: a CE Certificate from an EU Notified Body specifically for the Class III device (or a US FDA Pre-Market Approval (PMA) or TGA equivalent), as self-declaration is not accepted for Class III; a full Design Dossier (DD) with complete technical documentation; a full biological evaluation report per ISO 10993 covering cytotoxicity, sensitization, systemic toxicity, and implantation data (where applicable); a comprehensive clinical evaluation report with post-market clinical follow-up (PMCF) data; the manufacturer’s ISO 13485 certificate; and Arabic labeling approved per MOHAP standards. MOHAP registration fees for Class III run AED 20,000 to AED 50,000 per product. Review timelines are 9 to 18 months. Class III certificates require renewal every 2 years rather than the standard 5 years, and the distributor must maintain an active post-market surveillance system with adverse event reports submitted to MOHAP within 10 days of any serious incidents.
Are medical devices exempt from VAT in UAE?
Most medical devices in the UAE are zero-rated for VAT purposes (0%), not exempt in the strict tax sense — meaning the supply itself carries a 0% VAT rate and the supplier can still recover input VAT on costs. UAE Federal Decree-Law No. 8 of 2017 zero-rates “specified medical equipment” and “human medicine.” However, not every item sold by a medical device company automatically qualifies for zero-rating. Diagnostic consumables, non-therapeutic equipment (such as some aesthetic devices), and accessories used outside a clinical setting may be standard-rated at 5%. Medical device companies must classify each product correctly under UAE VAT law and, where there is ambiguity, obtain a private ruling from the Federal Tax Authority (FTA). The general import duty on medical devices is 0% under GCC Common Customs Tariff for most HS codes, giving UAE-based importers a further cost advantage versus regional competitors.